Data showed that at least 12 stocks, which were traded below Rs 1 in April 2013, have surged up to 208 times in the last 10 years, with Shukra Pharmaceuticals leading the pack with a rally of 20,744 per cent.

Crorepati stocks! How these 12 tiny stocks turned Rs 1 lakh to up to Rs 2 crore

With a market valuation of Rs. 30.34 crore, Shukra Pharmaceuticals Ltd. is a small cap company that operates in the pharmaceutical industry

Given multibagger return YTD, this pharma stock fixes record date for dividend

The board has also approved appointment of GYR Capital Advisors Private Limited (Merchant Banker) as lead manager.

Shukra Pharmaceuticals board approves rights issue worth Rs19 crore; Stock climbs 3.4%

Shukra Pharmaceuticals standalone net profit declines 76.19% in the December 2021 quarter

Shukra Pharmaceuticals standalone net profit declines 77.78% in the September 2021 quarter

Shukra Pharmaceuticals standalone net profit rises 100.00% in the June 2021 quarter

Shukra Pharmaceuticals reports standalone net loss of Rs 0.23 crore in the March 2021 quarter

Shukra Pharmaceuticals standalone net profit declines 50.00% in the December 2020 quarter

The creamy layer - amongst the top performing stocks

Performance

Seems to be overvalued vs the market average

Valuation

Strong financials and growth story over the years

Growth

Showing good signs of profitability & efficiency

Profitability

The stock is underpriced and is not in the overbought zone

Current price is less than the intrinsic value

Fundamentals

Good time to consider, stock is not in the overbought zone

Technicals

Entry point

The stock has a moderate number of red flags

Promoter pledged holding

Unsolicited messages

Default probability

Red flags

Shukra Pharmaceuticals is engaged in the business of manufacturing and trading of pharmaceuticals Products.